explore -WSS

explore

author：entertainment 2025-09-27 16:47:50 - browse：358

The biotech company Acelyrin, which raised more than $500 million in an IPO this year, ran into its first major setback Monday as its investigational anti-inflammatory drug missed the primary goal in a pivotal clinical trial.

Acelyrin’s medicine, a subcutaneous treatment called izokibep, is meant to clear up lesions for patients with the common skin disease hidradenitis suppurativa, or HS, an inflammatory disorder that leads to abscesses and scars. But after 16 weeks of treatment, patients who received izokibep did not show significant improvements compared to those taking a placebo, failing the study’s primary endpoint.

Acelyrin’s share price fell more than 60% in after-hours trading Monday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Medical experts exlpore how to eliminate bias in clinical algorithms

hotspot

WSS

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Supreme Court rules employers must be more accommodating of religious observance

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

The strange history of BMI, the body mass index

Roche’s Alnylam deal shows drug firms interested in heart drugs

What to watch for from Zogenix and Amicus clinical trials

entertainment

explore

Wikipedia

In Memoriam: Notable people who died in 2023

Why patients can’t get everything they want on drug pricing

How one medical school became remarkably diverse

ADA: All diabetes patients should be screened for liver condition

What does generative AI mean for health care? We asked experts

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

GOP inquiry over gain

Walensky prepares to leave CDC — and Congress — behind

Tuskegee Airman Raymond Cassagnol dies at 102

hotspot

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Why patients can’t get everything they want on drug pricing

The simple reason for the increase in autism diagnosis

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

focus

hotspot

hotspot

focus